Rachel Moseley is principal academic in psychology at Bournemouth University in the United Kingdom. Her research centers around issues that autistic adults face, including mental ill-health, suicidality, self-injury, aging and late diagnosis. She also investigates aspects of cognition and social communication in autistic people and how these differ depending on personal characteristics, such as sex.
Rachel Moseley
Principal academic
Bournemouth University
From this contributor
Autism and menopause: Q&A with Rachel Moseley and Julie Turner-Cobb
Menopause poses significant challenges for autistic people, according to a small survey published in 2020 — the first to explore the transition among people with autism traits.
Autism and menopause: Q&A with Rachel Moseley and Julie Turner-Cobb
Autism and eating disorders may have an emotional connection
Eating disorders have the highest mortality rates of any kinds of mental illness. They don’t discriminate, affecting people of all ethnicities, sexualities, gender identities, ages and backgrounds.
Autism and eating disorders may have an emotional connection
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.